TrialArthritis care & research2026

Cost-Effectiveness of Low-Dose Colchicine Prophylaxis When Starting Allopurinol Using the "Start-Low Go-Slow" Approach for Gout: Evidence From a Noninferiority Randomized Double-Blind Placebo-Controlled Trial.

Yana Pryymachenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.